Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Regeneron Pharmaceuticals Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
REGN
Nasdaq
8731
https://www.regeneron.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Regeneron Pharmaceuticals Inc
Pipeline Moves: Phase III completion for Corcept’s relaorilant
- May 13th, 2024 8:01 am
Dupixent® (dupilumab) sBLA Accepted for FDA Priority Review for Treatment of Adolescents with Chronic Rhinosinusitis with Nasal Polyposis (CRSwNP)
- May 13th, 2024 5:00 am
Regeneron Pharmaceuticals, Inc.'s (NASDAQ:REGN) large institutional owners must be happy as stock continues to impress, up 3.2% over the past week
- May 10th, 2024 11:00 am
Q1 2024 Intellia Therapeutics Inc Earnings Call
- May 10th, 2024 3:53 am
Regeneron’s gene therapy triumphs twice, restoring hearing in children
- May 9th, 2024 10:51 am
Regeneron gene therapy improves hearing in two children
- May 8th, 2024 11:30 am
Latest DB-OTO Results Show Dramatically Improved Hearing to Normal Levels in a Child with Profound Genetic Deafness within 24 Weeks and Initial Hearing Improvements in a Second Child at 6 Weeks
- May 8th, 2024 10:00 am
Regeneron Announces Investor Conference Presentations
- May 6th, 2024 8:05 pm
3 Biotech Stocks With the Potential to Make You an Overnight Millionaire
- May 4th, 2024 4:00 pm
23 Most Profitable Stocks of the Last 12 Months
- May 4th, 2024 11:38 am
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Q1 2024 Earnings Call Transcript
- May 3rd, 2024 2:15 pm
Regeneron Pharmaceuticals First Quarter 2024 Earnings: Misses Expectations
- May 3rd, 2024 1:01 pm
Shhh! 3 Secret Pharma Stocks Flying Below Wall Street’s Radar
- May 3rd, 2024 10:15 am
Regeneron Pharmaceuticals Inc (REGN) Q1 2024 Earnings Call Transcript Highlights: Key Financial ...
- May 3rd, 2024 7:10 am
Decoding Regeneron Pharmaceuticals Inc (REGN): A Strategic SWOT Insight
- May 3rd, 2024 5:08 am
Regeneron Reverses On Better-Than-Feared Eylea Sales As Patent Expiration Looms
- May 2nd, 2024 8:03 pm
Regeneron (REGN) Q1 Earnings, Sales Miss on Lower Eylea Sales
- May 2nd, 2024 2:01 pm
Regeneron (REGN) Reports Q1 Earnings: What Key Metrics Have to Say
- May 2nd, 2024 1:30 pm
Regeneron Pharmaceuticals Inc (REGN) Q1 2024 Earnings: Challenges and Opportunities Amidst ...
- May 2nd, 2024 12:32 pm
Is Weakness In Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects?
- May 2nd, 2024 12:00 pm
Scroll